Dr. Rose Nash is the Director of Research and Development at GT Molecular, where she oversees their national wastewater monitoring program that services over 100 communities around the United States. In this role, she oversaw the development and testing that led to identifying the first COVID-19 variant of concern ever detected in American wastewater. Previously, Rose served as the R&D Manager at InDevR, a Boulder biotechnology company developing new molecular tools to aid the influenza vaccine industry. Her training includes a Bachelor’s degree in Microbiology from Indiana University, a Doctorate in Microbiology from the University of Wisconsin-Madison, and two post-doctoral fellowships at the University of Colorado-Boulder.